Tunisia

Last Updated 24 January 2022.

7 Vaccines Approved for Use in Tunisia

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 136 countries

  58 trials in 24 countries

  Approval Source: santetunisie.rns.tn

  RNA

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 24 countries

  4 trials in 2 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 74 countries

  22 trials in 7 countries

  Approval Source: tass.com

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 106 countries

  18 trials in 18 countries

  Approval Source: sauve.tn

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 137 countries

  56 trials in 30 countries

  Approval Source: aa.com.tr

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  22 trials in 11 countries

  Approval Source: xinhuanet.com

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 52 countries

  29 trials in 9 countries

  Approval Source: xinhuanet.com

  Inactivated

0 Vaccines in Clinical Trials in Tunisia